Australian regulator weighs up under-12s COVID vaccination.
A crucial step has been taken towards approving a COVID-19 vaccine for children aged six to 12.
The Therapeutic Goods Administration has granted a "provisional determination" to Moderna Australia in relation to its COVID-19 vaccine, SPIKEVAX.
It means Moderna can apply to vary the provisional approval of its vaccine for use in children aged under 12.
Currently, SPIKEVAX is provisionally approved for use in people aged 12 years or older.
Moderna's COVID-19 vaccine (SPIKEVAX) - provisional determination granted for proposed use in children and booster shot for adults under evaluation. Find out more: https://t.co/NKL2CSz9ky pic.twitter.com/VQd3DFgEEN
— TGA Australia (@TGAgovau) November 10, 2021
Top Comments